153 related articles for article (PubMed ID: 34792721)
1. The clinicopathological characteristics and outcomes of IgA nephropathy with predominant lambda or kappa light-chain deposition.
Sun S; Di W; Li R; Yang X; Jia Q; Liu C; Ma F
Int Urol Nephrol; 2022 Jul; 54(7):1705-1712. PubMed ID: 34792721
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy.
Nagae H; Tsuchimoto A; Tsuruya K; Kawahara S; Shimomura Y; Noguchi H; Masutani K; Katafuchi R; Kitazono T
Clin Exp Nephrol; 2017 Apr; 21(2):266-274. PubMed ID: 27170372
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of light chain deposition in IgA nephropathy.
Katafuchi R; Nagae H; Masutani K; Nakano T; Munakata M; Tsuruya K; Mitsuiki K
Clin Exp Nephrol; 2021 Jun; 25(6):621-632. PubMed ID: 33646451
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescence characterization of light chains in human nephropathies.
Orfila C; Rakotoarivony J; Manuel Y; Suc JM
Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):591-4. PubMed ID: 3129870
[TBL] [Abstract][Full Text] [Related]
5. Light chain composition of IgA in IgA nephropathy.
Lai KN; Lai FM; Lo ST; Lam CW
Am J Kidney Dis; 1988 May; 11(5):425-9. PubMed ID: 3130751
[TBL] [Abstract][Full Text] [Related]
6. The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy.
Lai KN; Chan KW; Mac-Moune F; Ho CP; Yan KW; Lam CW; Vallance-Owen J
Am J Clin Pathol; 1986 May; 85(5):548-51. PubMed ID: 3085470
[TBL] [Abstract][Full Text] [Related]
7. Predominant synthesis of IgA with lambda light chain in IgA nephropathy.
Lai KN; Chui SH; Lai FM; Lam CW
Kidney Int; 1988 Feb; 33(2):584-9. PubMed ID: 3129610
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy.
Ravipati P; Freese RL; Royal V; Bu L; Canetta P; Gipson D; Kallash M; Kiryluk K; Nast C; Reich HN; Rheault MN; Saha M; Nachman PH;
Kidney Int Rep; 2022 Nov; 7(11):2462-2473. PubMed ID: 36531879
[TBL] [Abstract][Full Text] [Related]
9. Light-chain ratio of serum IgA1 in IgA nephropathy.
Chui SH; Lam CW; Lewis WH; Lai KN
J Clin Immunol; 1991 Jul; 11(4):219-23. PubMed ID: 1918269
[TBL] [Abstract][Full Text] [Related]
10. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
11. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy.
Chen N; Nusbaum P; Halbwachs-Mecarelli L; Lesavre P
Nephrol Dial Transplant; 1991; 6(11):846-50. PubMed ID: 1775249
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal IgA in IgA nephropathy.
Yasumoto Y; Suga T; Miura M; Nomoto H; Tomino Y; Nomoto Y; Sakai H
Ann Acad Med Singap; 1988 Jul; 17(3):427-30. PubMed ID: 3146241
[TBL] [Abstract][Full Text] [Related]
13. Light chain ratios of serum immunoglobulins in disease.
Lam CW; Chui SH; Leung NW; Li EK; Lai KN
Clin Biochem; 1991 Jun; 24(3):283-7. PubMed ID: 1908361
[TBL] [Abstract][Full Text] [Related]
14. Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay.
Suen KK; Lewis WH; Lai KN
Scand J Urol Nephrol; 1997 Jun; 31(3):289-93. PubMed ID: 9249895
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR.
Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J
Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric-based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases.
Moore AR; Brown K; Chapman C; Broeckling C
Vet Comp Oncol; 2023 Sep; 21(3):460-468. PubMed ID: 37154287
[TBL] [Abstract][Full Text] [Related]
17. Charge distribution of IgA-lambda in IgA nephropathy.
Lai KN; Chui SH; Lewis WH; Poon AS; Lam CW
Nephron; 1994; 66(1):38-44. PubMed ID: 8107951
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Characteristics of Light and Heavy Chain Deposition Disease: A Case Series.
Wang Y; Chen D; Hu R; Zhang Y; Liang D; Xu F; Liu F; Zhu X; Lin Y; Yang X; Liu X; Xing G; Liang S; Zeng C
Am J Kidney Dis; 2024 May; ():. PubMed ID: 38750878
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and Prognostic Study of Primary IgA Nephropathy With Light Chain λ Restriction in the Mesangial Deposits.
Zhang J; Huang Z; Lin S; Hu Y; Liang Y; Qiu W; Chen B; Chen C
Kidney Int Rep; 2022 Apr; 7(4):776-785. PubMed ID: 35497802
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy.
Shima Y; Nakanishi K; Mukaiyama H; Tanaka Y; Wada T; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2021 Apr; 36(4):899-908. PubMed ID: 33011820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
